Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[IDDM treatment with an insulin-expressing vector].

T Takeuchi1

  • 1Institute for Molecular and Cellular Regulation, Gunma University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 20, 2001
PubMed
Summary

Engineered non-beta cells can be developed into functional beta-cell surrogates for insulin production. These strategies, combined with stem cell therapies, offer future diabetes treatment possibilities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[ESWL therapy of pancreatic calculi].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·1992
Same author

Role of cyclic AMP in prostaglandin-induced modulation of acetylcholine release from the myenteric plexus of guinea pig ileum.

Japanese journal of pharmacology·1992
Same author

Postnatal growth curves of very low birthweight Japanese infants.

Acta paediatrica Japonica : Overseas edition·1992
Same author

Cytomegalic inclusion disease presenting acute intrahepatic cholestasis.

Internal medicine (Tokyo, Japan)·1992
Same author

The structure of pyrizinostatin.

The Journal of antibiotics·1992
Same author

In vitro effects of glycosylated insulin and glucagon in perfused liver of the rat.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1992

Area of Science:

  • Biotechnology
  • Cell Biology
  • Endocrinology

Context:

  • Islet transplantation is effective but limited by donor scarcity.
  • Engineering non-beta cells to produce insulin emerged in the late 1980s.
  • Current research focuses on creating functional beta-cell surrogates.

Purpose:

  • To explore methods for achieving regulated insulin production and secretion from engineered non-beta cells.
  • To develop viable alternatives to pancreatic islet transplantation for diabetes treatment.

Summary:

  • Researchers are engineering non-beta cells (e.g., hepatocytes, myocytes) to function as insulin-producing beta-cells.
  • Key strategies include optimizing proinsulin processing and regulated insulin secretion.
  • These engineered cells aim to mimic the function of natural pancreatic beta cells.

Impact:

  • Successful development of beta-cell surrogates could alleviate donor limitations in transplantation.
  • This approach holds promise for novel diabetes therapies by regenerating insulin-producing capacity.
  • Integration with stem cell-based islet regeneration offers a comprehensive strategy for diabetes management.

Related Experiment Videos